Saturday, June 27, 2026

HomeGeneral NewsPfizr BioNTech trial fails on 2 to 5-year-olds

Pfizr BioNTech trial fails on 2 to 5-year-olds

- Advertisement -


Newly released data by Pfizer presents a worrying omen for getting younger children vaccinated against Covid.

A low dose of the Pfizer-BioNTech coronavirus vaccine failed to produce an adequate response in children aged two to five years of age.

The companies announced the results from ongoing…



Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed